Ryvu Therapeutics Valuation
RVU Stock | 60.00 15.75 35.59% |
the company is overvaluedRyvu Therapeutics holds a recent Real Value of USD46.14 per share. The prevailing price of the company is USD60.0.
Additional Tools for Ryvu Stock Analysis
When running Ryvu Therapeutics' price analysis, check to measure Ryvu Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ryvu Therapeutics is operating at the current time. Most of Ryvu Therapeutics' value examination focuses on studying past and present price action to predict the probability of Ryvu Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ryvu Therapeutics' price. Additionally, you may evaluate how the addition of Ryvu Therapeutics to your portfolios can decrease your overall portfolio volatility.